|
|
 |
|
About Cartesia Dx
|
| |
|
|
Cartesia Dx was incorporated in July 2006 to commercialize technology developed in a collaboration
with the University of Pittsburgh, UPMC Children’s Hospital and Carnegie Mellon University.
Cartesia Dx has received initial investments from Pittsburgh Life Sciences Greenhouse and Idea Foundry.
|
|
|
|
Fred Marroni, President & CEO
|
Fred Marroni is a successful executive with over twenty years of engineering and executive management experience.
Prior to co-founding Cartesia Dx in 2006, Mr. Marroni’s work with the Pittsburgh Life Sciences Greenhouse was instrumental
in the creation and funding of six start-up companies and he has been responsible for the commercialization of several
first-of-the-kind products in multiple industries.
Mr. Marroni has served as Vice President of Engineering and Development
for NOMOS Corporation, a pioneering company in the field of radiation treatment for cancer therapy. While at NOMOS, he
was responsible for new product research, systems design, and product integration. He was also responsible for several
aspects of the successful merger of NOMOS with North American Scientific, Inc. (NASDAQ: NASI) in 2004. He holds a BSIE
degree from Pennsylvania State University.
|
| |
|
Mike Formica, Director of Product Development
|
Mike Formica is a seasoned entrepreneur with an extensive background in new product development & introduction. He has
spent the last 15 years commercializing products ranging from semiconductor capital equipment to sophisticated driver
assistance devices for cars and trucks. Most recently, Mr. Formica was CEO of AssistWare Technology where he transformed
their platform into a viable product. Their successful launch into the commercial marketplace led to their acquisition by
Cognex Corporation in 2006.
Mr. Formica has won several awards including twice being named a '"Rising Star" by the Pittsburgh Technology Council and
developing four different products that were named 'Best Product’ by their respective industries. Mr. Formica is a former
US Navy Nuclear Power Officer and holds a BSEE from the University of Pittsburgh.
|
| |
|
Damion Shelton, PhD, Technical Development
|
Damion Shelton, PhD, is responsible for system development of the Arthritis Imager™. He graduated from Carnegie Mellon
University with a Ph.D. in Robotics in 2007, and previously received an M.S. in Robotics from Carnegie Mellon and a B.S.
in Bioengineering from the University of Pittsburgh. Dr Shelton has author over 16 peer reviewed papers and was the
recipient of a graduate fellowship from the Whitaker Foundation.
Dr. Shelton has over 10years of experience developing
medical applications which includes medical imaging, augmented reality, and computer assisted surgery. He received a
15-month grant from the Beckman Foundation to pursue an in-depth internship to design and develop computer software to aid
in the construction of 3D models from CT and MRI scans.
|
|
|
|
Scientific Advisory Board
|
Raphael Hirsch, M.D.
Dr. Hirsch, is the Aldo V. Londino Jr., MD, Professor of Pediatrics and chief of the Division of Pediatric
Rheumatology at Children's Hospital of Pittsburgh. He came to Pittsburgh in 2002, bringing a rich background in
research, clinical care and teaching to the hospital and its patients. Under his direction, Children's pediatric
rheumatology program has grown to one of the largest and most comprehensive programs in the United States.
Dr. Hirsch
leads an NIH-funded research program focused on answering fundamental questions about arthritis. His areas of expertise
include gene transfer, gene expression in arthritis, modulation of T-cell immune responses and therapy of autoimmune
diseases. Dr. Hirsch is board-certified in pediatrics and pediatric rheumatology. He earned a bachelor's degree in
biology from Northwestern University, Chicago, in 1979 and his medical degree from the University of Illinois College of
Medicine in 1983.
|
| |
C. Kent Kwoh, M.D.
Dr. Kwoh, professor of medicine in the Division of Rheumatology at the University of Pittsburgh School of Medicine,
is a leading clinical and academic researcher in rheumatology. His clinical interests include rheumatoid arthritis
and general rheumatology, and his research interests include prevention of osteoarthritis, epidemiology in rheumatic
diseases, ethnic disparities in rheumatic diseases and rehabilitation/orthopaedic outcomes.
Dr. Kwoh is a member of
the board of directors of the ACR and an associate editor of Arthritis Care and Research. He is also principle
investigator of the University of Pittsburgh Arthritis Institute’s $8.9 million Osteoarthritis Initiative (OAI) grant
from the National Institute of Arthritis and Muscoloskeletal and Skin Diseases. Board certified in internal medicine
and rheumatology, Dr. Kwoh received his medical degree from the University of Illinois and completed his residency at
University of Illinois Hospitals.
|
| |
James Osborn
Jim "Oz" Osborn is Executive Director for the Quality of Life Tech Center, a unique partnership between Carnegie Mellon
and the University of Pittsburgh that brings together a cross-disciplinary team of technologists, clinicians, industry
partners, end users, and other stakeholders to create revolutionary technologies that will improve and sustain the
quality of life for all people. From 1985 through 1999, he held research and management positions in Carnegie Mellon’s
Robotics Institute and led several multi-million dollar robotics R&D projects sponsored by the US DOE, NASA and industry.
Mr. Osborn serves as a board member of several professional society robotics divisions, and authored 25 papers and
technical reports on robotic systems. He holds a Bachelor’s degree in Electrical and Biomedical Engineering and a
Master’s degree in Civil and Biomedical Engineering, both from Carnegie Mellon University.
|
|